Related by context. All words. (Click for frequent words.) 77 selective antagonist 77 non thiazolidinedione TZD 76 5 HT2A inverse 76 highly selective inhibitor 75 irreversible inhibitor 75 reversible inhibitors 75 selective inhibitor 75 selectively inhibits 74 sodium glucose cotransporter 74 ENMD # 73 receptor tyrosine kinase inhibitor 73 cortisol synthesis 73 5 HT4 receptor 73 investigational humanized monoclonal antibody 73 selective agonist 73 IAP inhibitor 73 potent inhibitor 73 multi kinase inhibitor 73 AAG geldanamycin analog 73 small molecule tyrosine 73 Factor Receptor 73 inverse agonist 72 partial agonist 72 vesicular monoamine transporter 72 peripherally restricted 72 orally administered inhibitor 72 Janus kinase 72 liposomal formulation 72 orally bioavailable 72 5 HT2A receptor 72 cyclin dependent kinase inhibitor 72 SGLT2 inhibitor 72 potently inhibits 72 PI3K/mTOR 72 CYP#A# CYP#D# 72 5 HT6 receptor 72 aurora kinase inhibitor 72 5 HT2A serotonin 71 #beta HSD1 71 Protein Kinase C 71 poly ADP ribose polymerase 71 small molecule inhibitor 71 CYT# potent vascular disrupting 71 pan histone deacetylase 71 AKT inhibitor 71 dasatinib Sprycel ® 71 PDE4 inhibitor 71 serine threonine 71 potently inhibited 71 plasma kallikrein inhibitor 71 selective kinase inhibitor 70 ADP receptor antagonist 70 adrenoceptor agonist 70 alpha 2A 70 sulfonylhydrazine class 70 kinase inhibitor 70 alpha 2A adrenoceptor 70 pan HDAC inhibitor 70 IMiDs R 70 PNP inhibitor 70 novel orally administered 70 histone deacetylase inhibitor 70 selective inhibition 70 positive allosteric modulator 70 thyroid hormone receptor 70 MTP inhibitor 70 imatinib Gleevec ® 70 non nucleoside inhibitor 70 Kinase Inhibitor 70 mediated apoptosis 70 oral prodrug 70 NS5b 70 IMiDs ® 70 novel histone deacetylase 70 2A receptor agonist 70 histone deacetylase 70 dual PPAR peroxisome 70 dopamine D2 70 PTP 1B 70 cyclooxygenase COX 70 DNA intercalator 70 pro apoptotic 70 NMDA N 70 TRPV1 agonist 70 receptor modulator 70 hypoxia inducible factor 70 signal transduction inhibitor 70 topoisomerase II inhibitor 70 GMX# 69 phosphatidylinositol 3 69 novel VDA molecule 69 NS5B polymerase 69 mitotic kinesin 69 alpha 2A adrenergic 69 protein tyrosine phosphatase 1B 69 Aurora Kinase 69 Tumor necrosis factor 69 Hsp# Inhibitor 69 potently inhibit 69 histone deacetylase HDAC inhibitor 69 potent inhibition 69 ARRY # 69 Janus Kinase 69 agonistic human 69 receptor partial agonist 69 deacetylase 69 selective modulator 69 selectively inhibited 69 agent VDA 69 agonist compounds 69 brivanib 69 hypoxia activated prodrug 69 type glutamate receptor 69 gamma secretase inhibitor 69 polymerase inhibitor 69 HCV protease 69 Preclinical studies suggest 69 alpha folate receptor 69 Orally administered 69 MKC# MT 69 induces apoptosis 69 pralatrexate injection folate analogue 69 c Raf kinase 69 peptibody 69 PEGylated Fab fragment 69 HSP# inhibitor 69 2 methoxyestradiol 69 erlotinib Tarceva ® 69 MEK inhibitor 69 pathophysiological effects 69 KSP inhibitor 69 proliferator activated receptor 69 mTOR mammalian target 69 5 HT4 69 monocyte chemotactic protein 69 antimitotic 69 Upregulation 69 #HT# 69 negative allosteric modulator 69 prostanoid 69 Topoisomerase II 69 TLR8 agonist 69 accumulate preferentially 69 Angiotensin Converting Enzyme 68 Interferon gamma 68 PPAR peroxisome proliferator activated 68 Mg Usa 68 sunitinib Sutent ® 68 anti amnesic 68 mGluR2 NAM 68 MEK ERK 68 receptor subtype 68 PRT# 68 5 lipoxygenase 68 VEGF receptors 68 kinase PI3K 68 Carfilzomib 68 THR beta agonist 68 protein kinase inhibitor 68 Silodosin 68 dasatinib Sprycel 68 converting enzyme 68 downregulates 68 matrix metalloproteases 68 kidney urologic 68 cyclooxygenase 68 potent inhibitors 68 receptor agonist 68 4E BP1 68 microsomal triglyceride transfer 68 M2 subunit 68 regulated kinase 68 novel peptide 68 hyperphosphorylation 68 p# alpha [001] 68 mu opioid receptor antagonist 68 MET VEGFR2 68 targeted radiotherapeutic 68 c MET 68 Receptor Antagonist 68 anionic backbone 68 MEK1 68 methyl D aspartate 68 Tyrima 68 FGFR 68 RAS MAPK pathway 68 nicotinic acetylcholine receptor 68 IGF1R 68 sphingosine 1 68 HCV NS5B polymerase 68 delta isoform 68 5 hydroxytryptamine 68 selective inverse agonist 68 related apoptosis inducing 68 mda 7 68 selective inhibitors 68 Bruton tyrosine kinase 68 HDAC Inhibitor 68 norepinephrine reuptake inhibitor 68 cell adhesion molecule 68 Cathepsin B 68 receptors PPARs 68 Kinoid 68 Epothilones 68 Cytochrome P# 68 Tyrosine Kinase Inhibitor 68 generation antisense inhibitor 68 inhibitor COX 68 P2Y 68 alpha#beta# integrin 68 Flt3 68 selective phosphodiesterase 68 Pruvel TM 68 Vidofludimus 68 Alfacell proprietary ribonuclease 67 thromboxane A2 67 gamma amino butyric 67 D aspartate NMDA receptor 67 NS#/#A protease 67 certain protein tyrosine 67 targeted antifolate 67 HCV RNA polymerase 67 HepDirect prodrug 67 secretory phospholipase A2 67 Gleevec resistant 67 mitogen activated protein kinase 67 nilotinib Tasigna ® 67 Pathway Inhibitor 67 Bezielle 67 DG# compounds targeting 67 Talabostat 67 mediated inhibition 67 small molecule agonists 67 JAK#/JAK# 67 apoptosis proteins 67 metabotropic glutamate receptor 67 Factor VIIa 67 PDGFR B 67 acyltransferase 67 p# mitogen activated 67 investigational oral inhibitor 67 small molecule activator 67 M1 muscarinic 67 mitogen activated ERK kinase 67 aurora kinase 67 generation purine nucleoside 67 neuroprotective properties 67 Vascular Disrupting Agent 67 CCR1 67 PDGFR 67 Enzastaurin 67 Tumor Necrosis Factor 67 PI3 Kinase 67 Interferon alpha 67 Omacetaxine 67 glucagon receptor 67 Parathyroid hormone 67 inhibit oxidative stress 67 phosphate S1P 67 Raf kinase 67 cytoprotective 67 HER1 67 interleukin IL -# 67 essential thrombocythemia ET 67 chemokine receptor 67 anti angiogenic agent 67 cyclooxygenase 2 67 calcitonin gene related 67 N methyl 67 proteasome inhibitor 67 enhance ApoA 67 targetters 67 peptidic compound 67 Telik logo TELINTRA 67 Mg Uk 67 antiapoptotic 67 CCR2 67 JAK1 67 Selective inhibition 67 delta gamma agonist 67 RON Notch 67 immunomodulating 67 receptor antagonist 67 receptor blocker 67 cortisol receptor 67 potent antiproliferative 67 selective immunoproteasome inhibitor 67 FasL 67 VEGF receptor 67 TNF Tumor Necrosis Factor 67 CD4 monoclonal antibody 67 5 HT1A receptor 67 Delta opioid receptor 67 receptor modulators 67 receptor inhibitor 67 Rigel R# 67 acetylcholinesterase AChE 67 sodium glucose transporter 67 ERK1 2 67 triggers apoptosis 67 Pharmacokinetics PK 67 TO AVOID PREGNANCY WHILE 67 Panzem R 67 specific lectin receptors 67 Angiotensin 67 peripherally acting 67 RAF kinase 67 orally dosed 67 2 inhibitor CYT# 67 MET RET 67 non porcine pancreatic 67 PI3K/Akt pathway inhibitor 67 cyclin dependent kinases CDKs 67 receptor agonists 67 antisense inhibitors 67 receptor antagonists 67 DNA methyltransferase inhibitors 67 AT1R 67 Eg5 67 vinca alkaloid 67 product candidate Lpathomab 67 mGluR5 antagonist 67 4 PDE4 enzyme 67 dihydrofolate reductase 67 selectively inhibiting 67 mGluR5 negative 67 PEGylated anti 66 kinesin spindle protein 66 mTOR inhibitors 66 SGLT2 66 Squalamine 66 inhibits protein synthesis 66 novel immunomodulatory 66 methionine aminopeptidase 66 aspartyl 66 demonstrated antitumor activity 66 NR2B selective 66 humanized monoclonal 66 kinase inhibition 66 lipoxygenase 66 Factor VEGF 66 histone deacetylase HDAC 66 CYP#A# substrate 66 humanized therapeutic 66 Panzem NCD 66 VEGFR2 inhibitor 66 Initiates Phase II 66 1α 66 hyaluronidase enzyme 66 mGluR4 66 specific protein tyrosine 66 PI3K inhibitor 66 nucleoside analog 66 Presents Preclinical Data 66 mineralocorticoid 66 apoptosis inducers 66 CORT # 66 binds selectively 66 multikinase inhibitor 66 oral JAK1 66 Tumour VDA 66 substrates inhibitors 66 Bosutinib 66 acetylcholinesterase 66 opioid receptor antagonist 66 inflammatory PDE 66 E2F 66 Fibroblast Growth Factor Receptor 66 neuronal nitric oxide synthase 66 alkylating agent 66 orally bioavailable mimics 66 histone deacetylation 66 CG# [003] 66 enzyme inhibitor 66 selective orally bioavailable 66 metaglidasen 66 CTAP# Capsules 66 antiproliferative effects 66 dihydrofolate reductase DHFR 66 uricase 66 TRAIL induced apoptosis 66 mertansine 66 receptor antagonism 66 factor TNF 66 TRAIL R2 66 Cyclooxygenase 66 Darinaparsin 66 Epidermal Growth Factor Receptor 66 antibody MT# 66 peroxisome proliferator activated 66 xenograft models 66 liposome encapsulated 66 folate analogue metabolic 66 cetuximab Erbitux R 66 XL# anticancer compounds 66 CD8 + cytotoxic 66 selective serotonin 2C receptor 66 pan Bcl 2 66 BRAF kinase 66 small molecule glucokinase 66 virus HCV protease inhibitor 66 histone acetyltransferase 66 vWF 66 FUSILEV enhances 66 selectively inhibit 66 MEK inhibitors 66 HER2 HER2 66 glutamic acid decarboxylase 66 HDACi 66 SGLT 66 R Saizen R 66 HER2 ErbB2 66 nucleotide analog 66 histone methyltransferase 66 humanised monoclonal antibody 66 Epothilone D 66 LymphoStat B belimumab 66 vascular disrupting agent 66 PKC inhibitor 66 cathepsin K inhibitor 66 glycogen synthase kinase 66 inhibitory effects 66 HMG CoA reductase inhibitors 66 #HT#A 66 highly selective endothelin 66 Receptor Antagonists 66 novel emulsion formulation 66 factor Xa 66 itraconazole Sporanox 66 tyrosine kinase inhibitor 66 molecule epidermal 66 N acetylgalactosamine 6 66 Polymerase Inhibitor 66 p# inhibitor 66 PI3K Akt 66 Personalized Immunotherapy 66 neurokinin 1 66 humanized anti 66 5 HT6 66 leukotriene pathway 66 retinoic acid receptor 66 Maribavir 66 thrombin receptor 66 adenosine receptor 66 phosphoprotein 65 5 lipoxygenase activating 65 beta 1a 65 Fc fusion protein 65 isoenzyme 65 selectively binds 65 p# MAPK 65 hepatic lipase 65 tumor vascular disrupting 65 protein secreted 65 ACC2 65 Hsp# inhibitors 65 triciribine phosphate monohydrate 65 cytidine nucleoside analog 65 RDEA# potent 65 Aurora kinase 65 histone deacetylases 65 Syk 65 DNA demethylating agent 65 immune modulating 65 induce apoptosis 65 activin receptor type 65 factor HGF 65 anti fibrotic 65 Recombinant Human 65 Macrophage 65 Valproic acid 65 Sphingosine 1 65 Initiates Enrollment 65 proteasome inhibitors 65 MAGE A3 ASCI 65 androgen receptor AR 65 Imatinib mesylate 65 ,#,# [002] 65 small molecule chemotherapeutic 65 Xanafide 65 angiogenesis inhibitor 65 leukocyte adhesion 65 Cyclooxygenase Inhibiting Nitric Oxide 65 targeting CD# 65 reuptake inhibitor 65 fosbretabulin 65 antisense inhibition 65 Hypoxia Inducible Factor 65 ATRA IV 65 MCSP respectively 65 Archexin 65 anti secretory 65 receptor PPAR 65 muscarinic 65 AN# topical anti 65 HGS ETR1 mapatumumab 65 5alpha reductase 65 intranasal formulation 65 N acetylgalactosamine 65 adecatumumab MT# 65 peroxidase 65 oral nucleoside analogue 65 ® lenalidomide 65 immune stimulatory 65 delta opioid receptor 65 proapoptotic 65 chemically modified siRNA 65 colorectal carcinoma 65 anticancer therapeutics 65 cytochrome P 65 chronic eosinophilic leukemia 65 JUVISTA R Human 65 HDAC enzymes 65 RNA antagonist 65 docetaxel Taxotere R 65 2A agonist 65 P#Y# [002] 65 Granulocyte Colony Stimulating Factor 65 cyclin dependent kinases 65 potent inducer 65 receptor CXCR4 65 chimeric monoclonal antibody 65 candidate DB# 65 Anti Tumor 65 huN# DM1 65 casein kinase 65 antiarrhythmic 65 thymidylate synthase 65 Presents Preclinical 65 Blinatumomab 65 potent suppressor 65 castrate resistant prostate cancer 65 albiglutide 65 cyclase 65 receptor activator 65 CYP #A# 65 selective antagonists 65 adrenoceptor 65 developing Bicifadine serotonin 65 DGAT 65 PPARγ 65 JAK inhibitor 65 antiangiogenic agent 65 Tumour Vascular Disrupting Agent 65 rxRNA 65 antisense oligonucleotide 65 VEGFR 65 Protein Kinase 65 mouse xenograft models 65 dipeptidyl peptidase 4 65 potent anticancer 65 CCR9 antagonist 65 CD# expressing 65 hormone LHRH antagonist 65 TNFalpha 65 Inosine 65 glycoprotein GP IIb IIIa 65 small molecule Hedgehog 65 cutaneous T 65 activate SIRT1 65 prodrugs 65 5 FU leucovorin 65 Akt activation 65 CCR2 receptor 65 CDK inhibitor 65 Inhibitor 65 GSK3B 65 heme oxygenase 65 calcium calmodulin dependent 65 mTOR inhibitor 65 Dasatinib 65 selectively activates 65 cholesteryl ester transfer 65 proprietary polysaccharide 65 Febuxostat 65 vascular disrupting agents 65 Initiate Phase 65 Angiolix R 65 vapreotide acetate 65 proto oncogene 65 HGS# 65 Completes Patient Enrollment 65 oral ghrelin agonist 65 Immunomodulatory 65 interleukin IL 65 pharmacologically active isomer 65 thalidomide Thalomid 65 tumors GIST 65 Angiotensin converting enzyme 65 P#Y# [001] 65 adipogenic 65 systemic RNAi therapeutic 65 GW# [003] 65 urate oxidase 65 Cathepsin S 65 platform HDL Mimetic 65 Investigational Oral 65 5 HT3 antagonist 65 Liposomal 64 ALN HPN 64 tubulin binding 64 peptide CGRP 64 immune modulator 64 volociximab 64 D aspartic acid 64 mitogenic 64 inhibitor PPI 64 Sapacitabine 64 lymphotoxin 64 selective estrogen receptor modulator 64 5HT 64 myelofibrosis polycythemia vera 64 tumor xenograft models 64 methyl CpG binding 64 P#X# antagonist 64 triggers apoptosis programmed 64 cytotoxic T lymphocyte 64 vinblastine 64 potent antitumor activity 64 Proteasome 64 inhibit angiogenesis 64 drug zotarolimus 64 Selective Inhibitor 64 coronary vasodilation 64 deacetylation 64 directed radiotherapeutic antibody 64 Darapladib 64 tyrosine kinase receptor 64 prescribed proton pump 64 oral dihydropyrimidine dehydrogenase DPD 64 huC# DM4 64 ERK pathway 64 non nucleoside HCV 64 5 HT3 receptor 64 anti leukemic 64 Bruton tyrosine kinase Btk 64 upregulates 64 Elvitegravir 64 delta selective PI3K 64 CCR5 antagonist 64 estramustine 64 protein tyrosine 64 type plasminogen activator 64 inhibit vascular endothelial 64 acetylcholine receptor 64 Receptor Agonist 64 EGF receptor 64 somatostatin 64 polysaccharide polymer 64 enkephalin 64 NS4A 64 topical gel formulation 64 ABLYNX 64 Antigen Specific 64 γ secretase 64 cytochrome p# 64 Akt signaling 64 neuropathic pain metabolic diseases 64 Overexpression 64 syngeneic 64 pancreatic islet beta 64 multitargeted 64 siRNA binds 64 PPAR gamma agonist 64 combines bupropion 64 Belerofon 64 Degarelix 64 1alpha 64 decarboxylase 64 matrix metalloproteinases MMPs 64 sphingosine kinase 64 RNA antagonists 64 HCV polymerase 64 depsipeptide 64 monoclonal antibody conjugated 64 Tarceva TM 64 NS5A 64 inhibit platelet function 64 immunomodulatory therapy 64 R lenalidomide 64 selective adhesion molecule 64 PSMA ADC 64 Histone deacetylase 64 PDE# 64 isoform selective 64 luteinizing hormone releasing 64 phosphatases 64 insulin sensitizing 64 upregulate 64 Ostabolin C TM 64 covalently linked 64 cisplatin resistant 64 NMDA antagonist 64 antiproliferative activity 64 immunostimulatory 64 pro angiogenic 64 JAK2 inhibitor 64 rapamycin kinase 64 OMP #R# 64 alpha TNFa 64 E selectin 64 hypoxia selective 64 gefitinib Iressa 64 CYP#A# isoenzyme 64 serine protease inhibitor 64 AEG# 64 PLA2 64 receptor tyrosine kinase 64 dipeptidyl peptidase IV 64 K ras mutations 64 ZFN modified 64 BRAF inhibitor 64 radiation sensitizer 64 Initiates Clinical Trial 64 ALB # 64 inhibit VEGF 64 adhesion molecule EpCAM expressing 64 candidate deforolimus 64 estrogen receptor antagonist 64 VMAT2 64 PI3 kinase 64 acetonide FA 64 FLT3 64 familial amyloidotic polyneuropathy FAP 64 bevacizumab Avastin R 64 Phase #b/#a clinical 64 Aflibercept 64 inhaled formulation 64 HDACs 64 mitogen activated protein 64 peroxisomal 64 Angiotensin II 64 downregulation 64 COX2 64 ErbB1 64 Alzheimer disease cognitive impairment 64 phospholipase A2 64 potent vasoconstrictor 64 beta amyloid peptide 64 lintuzumab SGN 64 BRAF V#E 64 Rho GTPase 64 Lixivaptan 64 CCX# 64 PPARg 64 Prolongs Survival 64 GVAX ® 64 dihydro 64 Zorbtive TM 64 cathepsins 64 designed dual Bcr 64 XL# inhibits 64 1beta 64 PKC beta 64 RANK Ligand 64 histone deacetylase inhibitors 64 VEGFR2 64 CDK cyclin dependent 64 adenosine A2A 64 anti proliferative 64 resolvin 64 immuno modulatory 64 JAK inhibitors 64 gemcitabine Gemzar ® 64 IL 1β 64 TRO# 64 neurotrophic 64 metalloproteinase 64 anaphase promoting complex 64 selective adenosine 64 Pruvel ™ 64 PSN# [002] 64 indinavir Crixivan 64 myeloproliferative diseases 64 Glucagon Like Peptide 64 defensin mimetic antibiotic 64 antifibrotic 64 MKC# MKC# PP 64 prostaglandin D2 64 antiangiogenic 64 HGS ETR2 64 Receives Orphan Drug Designation 64 intravesical instillation 64 Trandolapril 64 hyperphenylalaninemia HPA due 64 nitric oxide synthase 64 Novel Oral 64 prolyl 64 novel orally bioavailable 64 IgG1 monoclonal antibody 64 Xyfid TM 64 receptor kinase 64 intratumoral injection 64 Files IND 64 Phase 2b Clinical Trial 64 induced mucositis 64 CFTR cystic fibrosis transmembrane 64 HCV replication 64 ispinesib SB # 64 oral Janus kinase 64 neuronal nicotinic receptors NNRs 64 BCL2 64 monoclonal anti 64 Sudhir Agrawal D.Phil 64 prokinetic agent 64 HepG2 cells 64 iobenguane 64 Drug Candidate 64 mineralocorticoid receptor 64 epothilones 64 epithelial tumors 64 gastro intestinal inflammation 64 Crofelemer budesonide foam 64 ornithine decarboxylase 64 PF # [002] 64 investigational monoclonal antibody 64 polycythemia vera essential thrombocythemia 64 E#F# 64 5 Fluorouracil 64 microtubule inhibitor 64 TLR9 agonist 64 Deforolimus 64 Chemokine Receptor 64 Vidaza ® 64 HIF PH 64 anti miRs antisense oligonucleotide 64 mRNA antagonist 64 tumor vasculature 64 T#I mutant 64 Ovitrelle R Serostim 64 eotaxin 64 potential vanilloid 63 nanomolar range 63 Platelet Derived Growth 63 circulating endothelial cells 63 induced phosphorylation 63 acyl CoA 63 candidates Azedra TM 63 cyclin dependent kinase 63 Letairis ambrisentan 63 lead Aganocide compound 63 IL #p# 63 taxane resistant 63 gemcitabine Gemzar 63 prostaglandin E2 PGE2 63 tubulin inhibitor 63 SIRT2 63 antitumor 63 immunoregulatory 63 5 HT4 agonist 63 serine proteases 63 evaluating picoplatin 63 EGFR tyrosine kinase inhibitor 63 product platforms AZX# 63 cytochrome P# 63 aminolevulinic acid 63 serotonin reuptake 63 secretory phospholipase A2 sPLA2 63 rusalatide acetate 63 monocyte chemoattractant protein 63 humanized monoclonal antibodies 63 insulin sensitizers 63 oral immunomodulatory 63 Phase Ib clinical trials 63 intercellular adhesion molecule 63 nilotinib Tasigna 63 Tie2 63 small molecule thrombopoietin 63 metastatic malignant 63 polycythemia vera PV 63 constitutive activation 63 cis retinoic acid 63 phosphatidylinositol 63 Phase 2a Clinical Trial 63 antibody MAb 63 dexamethasone Decadron 63 MGd 63 extracellular signal 63 Ep CAM 63 MetAP2 63 TLR8 63 TRANSDUR ® 63 antisense inhibitor 63 hydrolase 63 cMet 63 Receptors GPCRs 63 Luteinizing Hormone Releasing Hormone 63 muscarinic receptor agonist 63 cytokines chemokines 63 p# inhibitors 63 superoxide dismutase 63 alpha antagonist 63 EP1 receptor 63 selective A2A adenosine receptor 63 stimulation modulator 63 including cyclosporine methotrexate 63 novel topoisomerase 63 small molecule defensin 63 oxidative stress inducer 63 Abl 63 covalently bound 63 monoclonal antibody MAb 63 progesterone receptor 63 glutamyl 63 stable nucleic acid 63 SGLT1 63 bile acid sequestrant 63 hydroxylase 63 LRAT 63 murine model 63 Cyclooxygenase 2 63 hepatoprotective agent 63 p# MAP kinase inhibitor 63 CFTR corrector 63 hepatotoxic 63 alpha#beta# 63 HCV NS3 protease 63 serine protease 63 fibrin deposition 63 Initiates Phase 63 FBPase 63 transient receptor 63 #beta HSD 1 63 biased ligand 63 Signaling Pathway 63 protein tyrosine kinase 63 cholecystokinin CCK 63 inhibit COX 63 RAF kinase VEGFR 63 PI 3K 63 apoptosis inducer 63 PAOD 63 systemically administered 63 VEGF induced 63 anticancer activity 63 receptor blockers 63 lamotrigine Lamictal 63 CD# CD# 63 MMP2 63 B lymphocyte stimulator 63 small molecule activators 63 Modulates 63 ribonucleotide reductase clinically validated 63 monoclonal antibody IgG1 Mab 63 Pimavanserin 63 corticosteroid dexamethasone 63 XP# XP# 63 diarrhea predominant irritable 63 peptide receptor 63 Parathyroid Hormone 63 Potassium Chloride Sodium Ascorbate 63 ERK signaling 63 mutational status 63 dexpramipexole 63 Dehydrogenase 63 adult mesenchymal stem 63 insulin sensitizer 63 Phosphorylation 63 REGN# 63 hypereosinophilic syndrome 63 class mGluR5 inhibitor 63 5 HT2C serotonin 63 FGFR3 63 isoenzymes 63 mTOR kinase 63 PI3 K 63 factor VIIa 63 S#P# 63 taxane derivative 63 AEGR 63 antitumor effects 63 cyclophosphamide methotrexate 63 cisplatin gemcitabine 63 phosphoinositide 3 63 PPARgamma 63 apoptotic pathway 63 thiazolides 63 attach auristatin 63 ganglioside 63 JAK2 Inhibitor 63 hypertrichosis occurred 63 angiotensin II receptor 63 inhibits plasma kallikrein 63 humanised antibody 63 MT# MEDI 63 MAPK pathway 63 PI3K/Akt pathway 63 Methylnaltrexone 63 transthyretin TTR 63 bevacizumab Avastin ® 63 cyclin dependent kinase CDK 63 neuroprotectant 63 oral picoplatin 63 Immunotherapeutic 63 ATL# [002] 63 nucleoside analogues 63 Locked Nucleic Acid LNA 63 TLK# 63 R roscovitine CDK cyclin